NFKB1 and primary cutaneous T-cell non-Hodgkin lymphoma: In early stages of CTCL, autocrine tumor necrosis factor alpha (TNFα) expression increases NF-κB activation that leads to cellular proliferation and resistance to apoptosis [16, 17].